DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
N Engl J Med 1998;
338 (21) 1488-1497
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.